HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramaswamy Bhuvaneswari Selected Research

Povidone (Crospovidone)

1/2009In-vivo optical detection of cancer using chlorin e6--polyvinylpyrrolidone induced fluorescence imaging and spectroscopy.
8/2008Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer.
1/2007Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model.
11/2006The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy.
8/2006Fluorescence imaging and phototoxicity effects of new formulation of chlorin e6-polyvinylpyrrolidone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ramaswamy Bhuvaneswari Research Topics

Disease

17Neoplasms (Cancer)
01/2019 - 11/2006
6Urinary Bladder Neoplasms (Bladder Cancer)
09/2011 - 08/2006
5Hypoxia (Hypoxemia)
09/2011 - 10/2007
4Carcinoma (Carcinomatosis)
10/2011 - 08/2006
3Mouth Neoplasms (Oral Cancer)
02/2016 - 07/2011
3Necrosis
05/2010 - 11/2006
3Hemangiosarcoma (Angiosarcoma)
08/2008 - 10/2007
2Neoplasm Metastasis (Metastasis)
02/2016 - 05/2010
2Phototoxic Dermatitis (Phototoxicity)
08/2008 - 08/2006
1Squamous Cell Carcinoma of Head and Neck
02/2016
1Carcinogenesis
05/2010
1Colorectal Neoplasms (Colorectal Cancer)
12/2007
1Nasopharyngeal Carcinoma
10/2007

Drug/Important Bio-Agent (IBA)

141-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2017 - 08/2006
8Photosensitizing Agents (Photosensitizers)IBA
01/2017 - 10/2007
7phytochlorinIBA
02/2016 - 08/2006
6Pharmaceutical PreparationsIBA
07/2009 - 08/2006
5Oxygen (Dioxygen)IBA
05/2015 - 12/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2011 - 10/2007
5Povidone (Crospovidone)IBA
01/2009 - 08/2006
3ErbB Receptors (EGF Receptor)IBA
02/2016 - 11/2009
3Cetuximab (Erbitux)FDA Link
05/2015 - 11/2009
3chlorinIBA
05/2015 - 08/2006
3Bevacizumab (Avastin)FDA Link
09/2011 - 12/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2010 - 10/2007
3Angiogenesis InhibitorsIBA
11/2009 - 10/2007
3hypericinIBA
06/2008 - 10/2007
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2008 - 10/2007
2Angiogenic ProteinsIBA
06/2008 - 12/2007
2chlorophyllin (copper chlorophyll)IBA
01/2007 - 08/2006
2SaltsIBA
11/2006 - 08/2006
1VirosomesIBA
02/2016
1nimotuzumabIBA
05/2015
1Ferrosoferric Oxide (Magnetite)FDA Link
10/2010
1Proteins (Proteins, Gene)FDA Link
10/2010
1AntibodiesIBA
10/2010
1Tyrosine (L-Tyrosine)FDA Link
11/2009
1RNA (Ribonucleic Acid)IBA
11/2009
1PolymersIBA
08/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2008
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2008
1Interferon-alpha (Interferon Alfa)IBA
06/2008
1Monoclonal AntibodiesIBA
12/2007
1CytokinesIBA
12/2007
1Celecoxib (Celebrex)FDA Link
10/2007
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2007
1Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
08/2006

Therapy/Procedure

16Photochemotherapy (Photodynamic Therapy)
01/2019 - 08/2006
6Therapeutics
05/2015 - 12/2007
2Lasers (Laser)
10/2011 - 07/2011
2Drug Therapy (Chemotherapy)
07/2009 - 12/2007
2Intravenous Administration
08/2008 - 11/2006
1Radiotherapy
07/2009
1Topical Administration
01/2007